Gunay, F. S. D. Et Al. 2019. Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer. CLINICAL COLORECTAL CANCER , vol.18, no.2 .

Gunay, F. S. D., KIRMIZI, B. A., ENSARİ, A., Icli, F., & AKBULUT, H., (2019). Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer. CLINICAL COLORECTAL CANCER , vol.18, no.2.

Gunay, Fatma Et Al. "Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer," CLINICAL COLORECTAL CANCER , vol.18, no.2, 2019

Gunay, Fatma S. Et Al. "Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer." CLINICAL COLORECTAL CANCER , vol.18, no.2, 2019

Gunay, F. S. D. Et Al. (2019) . "Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer." CLINICAL COLORECTAL CANCER , vol.18, no.2.

@article{article, author={Fatma Sena Dost Gunay Et Al. }, title={Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer}, journal={CLINICAL COLORECTAL CANCER}, year=2019}